RT Journal Article
T1 The prevalence of Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) at testing centers in Belgium, Germany, Spain, and the UK using the cobas TV/MG molecular assay.
A1 Perry, Michael D
A1 Jones, Sophie
A1 Bertram, Alexander
A1 de Salazar, Adolfo
A1 Barrientos-Duran, Antonio
A1 Schiettekatte, Gilberte
A1 Lewinski, Michael
A1 Arcenas, Rodney
A1 Hansra, Avneet
A1 Njoya, Merlin
A1 Garcia, Federico
K1 Molecular diagnostics
K1 Mycoplasma genitalium
K1 PCR
K1 Public health
K1 Trichomonas vaginalis
K1 cobas TV/MG
AB Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) can lead to long-term sequelae in males and females; however, global prevalence data vary between geographical regions, as these sexually transmitted infections are not included in routine screening. The objective of this study was to use the cobas® TV/MG assay to assess the point prevalence of TV and MG in specimens from men and women over a broad European geographical area. Urine, vaginal, endocervical, and rectal samples were collected from patients aged ≥ 18 years receiving Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) screening as per local standard of care at sites in Belgium, Germany, Spain, and the UK (Wales). Remnant samples were assessed using the cobas TV/MG assay. Analysis of 2795 samples showed that MG prevalence varied slightly across female sample types (range: 1.7-5.8%; p = 0.0042). MG prevalence was higher in male rectal samples (12.5%) than in male urine samples (3.9%; p 
PB Springer
YR 2022
FD 2022-11-04
LK http://hdl.handle.net/10668/20397
UL http://hdl.handle.net/10668/20397
LA en
NO Perry MD, Jones S, Bertram A, de Salazar A, Barrientos-Durán A, Schiettekatte G, et al.  The prevalence of Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) at testing centers in Belgium, Germany, Spain, and the UK using the cobas TV/MG molecular assay. Eur J Clin Microbiol Infect Dis. 2023 Jan;42(1):43-52.
DS RISalud
RD Apr 5, 2025